<p>In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.</p>

In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.

CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Share CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome

Sign up to save your podcasts

CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome

CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome

More shows like Neurology® Podcast

NEJM This Week

JAMA Clinical Reviews

Practical Neurology Podcast

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

JAMA Neurology Author Interviews

Core IM | Internal Medicine Podcast

Neurology Today in 5

Annals On Call Podcast

Navigating Neuropsychology

The Clinical Problem Solvers

Neurology Minute

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio